We discover exceptional scientists before they've incorporated their companies. Pre-Seed is the only stage where a founder's track record matters more than their ability to fundraise. With the patent cliff bringing $170B of M&A opportunities by 2030, we're positioned at the earliest stage of the next generation of biotech unicorns.
Identify exceptional founders hidden in academic labs and research institutions worldwide.
Bring founders into our global residency houses for 3-6 months of intensive support and mentorship.
Make initial $10K checks, with up to $100K follow-on for exceptional founders and teams.
Support teams through Series A and beyond. Our portfolio companies become the next generation of biotech leaders.
Our flagship San Francisco residency currently houses approximately 20 exceptional founders across cell therapy, oncology, and biotech tools verticals.
Active grant disbursement program supporting early-stage founders with non-dilutive capital and technical resources.
Strategic partnerships with Astera Institute for biosecurity innovation and BlueDot Impact for global health tech acceleration.
Building the future of biotech at the earliest stage. Passionate about discovering exceptional founders hidden in labs and transforming them into unicorn builders.
Deep expertise in biotech operations and founder development. Drives our portfolio companies from pre-seed through Series A scaling.
We're always looking for exceptional founders and partners who share our vision of democratizing biotech innovation.
Request Deck